Home › Kanser sa Esophagus › California › Baldwin Park
Pag-aaral pangklinika para sa Kanser sa Esophagus sa Baldwin Park, CA
14 pag-aaral para sa Kanser sa Esophagus ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Baldwin Park (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Nagre-recruitPhase 1
- City of Hope National Medical Center, Duarte · 4 mi ang layo
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Nagre-recruitPhase 2
- City of Hope - Duarte Cancer Center, Duarte · 4 mi ang layo
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 2
- City of Hope, Duarte · 4 mi ang layo
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Nagre-recruitPhase 1
- City of Hope National Medical Center, Duarte · 4 mi ang layo
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Nagre-recruitPhase 1
- City of Hope Cancer Center, Duarte · 4 mi ang layo
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Nagre-recruitPhase 3
- City of Hope National Cancer Center, Duarte · 4 mi ang layo
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Nagre-recruitPhase 3
- Research Site, Duarte · 4 mi ang layo
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Nagre-recruitPhase 1
- City of Hope National Medical Center /ID# 276272, Duarte · 4 mi ang layo
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Nagre-recruit
- Beckman Research Institute of City of Hope, Duarte · 4 mi ang layo
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- City of Hope, Duarte · 4 mi ang layo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Duarte · 4 mi ang layo
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Nagre-recruitPhase 1/2
- City of Hope, Duarte · 4 mi ang layo
Pag-aaral para sa Kanser sa Esophagus sa ibang lungsod
- Houston, TX36 pag-aaral
- Boston, MA23 pag-aaral
- New York City, NY22 pag-aaral
- Nashville, TN19 pag-aaral
- St. Louis, MO17 pag-aaral
- Pittsburgh, PA15 pag-aaral
- Los Angeles, CA15 pag-aaral
- Grand Rapids, MI14 pag-aaral
- Philadelphia, PA13 pag-aaral
- San Antonio, TX12 pag-aaral
- Dallas, TX11 pag-aaral
- Rochester, MN11 pag-aaral
Iba pang pag-aaral sa Baldwin Park
- Kanser sa Suso44 pag-aaral
- Acute Myeloid Leukemia40 pag-aaral
- Colorectal Cancer37 pag-aaral
- Non-Small Cell Lung Cancer36 pag-aaral
- Kanser (lahat ng uri)34 pag-aaral
- Kanser sa Prostate30 pag-aaral
- Metastatic Cancer30 pag-aaral
- Myelodysplastic Syndromes26 pag-aaral
- Kanser sa Ovary25 pag-aaral
- Kanser sa Baga24 pag-aaral
- Multiple Myeloma23 pag-aaral
- Kanser sa Tiyan22 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.